CLOPIDOGREL FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) Application WO-2022117862-A1 World Intellectual Property Organisation (WIPO) 09 Jun 2022